Paradigm stock

Paradigm Stock

HealthTech
Founded: 2020Funding to Date: $203Mhttps://www.paradigm.inc

Paradigm operates a health technology platform designed to support the clinical research ecosystem. The platform's purpose is to enhance the efficiency of clinical trials by connecting biopharmaceutical trial sponsors with healthcare providers and streamlining the process for patients. Paradigm aims to improve the healthcare sector by increasing trial efficiency, lowering participation barriers for healthcare providers, and accelerating the delivery of potentially life-saving treatments to patients.

Investors Include:

Mubadala Capital, BrightEdge, General Catalyst, ARCH Venture Partners, Magnetic Ventures, AIM13 CV Partners, GV, Lux Capital, American Cancer Society, F-Prime Capital, Rsquared.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Management Team

Jonathan HirschChief Strategy and Growth Officer
Kent ThoelkeChief Executive Officer & Board Member
Michelle LeeChief Operating Officer
Elijah MeersonChief Technology Officer
Jay TrepanierChief Financial Officer

Board Members

Elena VibochBoard Member
Hemant TanejaBoard Member
Robert NelsenBoard Member
Stephen Knight MDBoard Member
Kenneth FrazierBoard Member

Paradigm’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Centivo stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Egenesis stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
FogPharma stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Pager stock
Paradromics stock
Pathalys Pharma stock
Pelago stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
Sionna stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock